• 대한의생명과학회지
• /
• 제24권3호
• /
• pp.280-284
• /
• 2018

The incidence of cardiovascular diseases (CVDs) is increasing rapidly in developed countries, with CVDs now representing the leading cause of morbidity and mortality. Natural products and ethnomedicines have been shown to reduce the risk of CVDs. Garlic is a medicinal plant used throughout the world for its anti-inflammatory, antioxidant, and antiplatelet activities. Chitosan is a natural polysaccharide obtained from chitin, and derivatives of chitosan have been shown to inhibit platelet aggregation and adhesion. We hypothesized that fermented preparations of these products may possess stronger antiplatelet effects than the non-fermented forms owing to the increased bioavailability of the bioactive compounds produced during fermentation. Therefore, we compared these compounds via in vitro and ex vivo platelet aggregation assays by using standard light transmission aggregometry and ex vivo granule secretions from rat platelets. We found that fermented preparations exerted more potent and significant inhibition of platelet aggregation both in vitro and ex vivo. Likewise, ATP release from dense granules of platelets was also significantly inhibited in fermented preparation-treated rat platelets compared to that in non-fermented preparation-treated ones. We concluded that fermented preparations exerted more potent effects on platelet function both in vitro and ex vivo, possibly as a result of the increased bioavailability of active compounds produced during fermentation. We therefore suggest that fermented products may be potent therapeutics against platelet-related CVDs and can be used as antiplatelet and antithrombotic agents.

• 약학회지
• /
• 제41권4호
• /
• pp.399-406
• /
• 1997

The effects of different $K^+$ channel blockers were investigated on the non-adrenergic non-cholinergic (NANC) relaxations in the circular muscle of the rabbit proximal stomach. Non-selective blockers of $K^+$ channels, 4-aminopyridine (4-AP, 3~30${\mu}M$) and tetraethylammonium (TEA, 100~1000${\mu}M$) significantly enhanced the NANC relaxations in a concentration-dependent manner. The enhancement was more prominent for the NANC relaxations induced by the electric field stimulation (EFS) with lower frequencies. Blockers of large conductance $Ca^{2+}$-activated $K^+$ channels, charybdotoxin and iberiotoxin, a blocker of small conduntance $Ca^{2+}$-activated $K^+$ channels, apamin and a blocker of ATP-sensitive $K^+$ channels, glibenclamide had no effect on the NANC relaxations, respectively. Exogeneous administration of nitric oxide (NO, 1~30${\mu}M$) caused concentration-dependent relaxations which showed a similarity to those obtained with EFS. None of the $K^+$ channel blockers had an effect on the concentration-dependent relaxation in response to NO. These results suggest that prejunctional $K^+$ channels regulate the release of NO from the NANC nerve in the rabbit proximal stomach as the inhibition of prejunctional $K^+$ channels increases the NANC relaxation induced by the EFS.

• Journal of Microbiology and Biotechnology
• /
• 제32권12호
• /
• pp.1527-1536
• /
• 2022

Escherichia coli can use allantoin as its sole nitrogen source under anaerobic conditions. The ureidoglycolate produced by double release of ammonia from allantoin can flow into either the glyoxylate shunt or further catabolic transcarbamoylation. Although the former pathway is well studied, the genes of the latter (catabolic) pathway are not known. In the catabolic pathway, ureidoglycolate is finally converted to carbamoyl phosphate (CP) and oxamate, and then CP is dephosphorylated to carbamate by a catabolic carbamate kinase (CK), whereby ATP is formed. We identified the ybcF gene in a gene cluster containing fdrA-ylbE-ylbF-ybcF that is located downstream of the allDCE-operon. Reverse transcription PCR of total mRNA confirmed that the genes fdrA, ylbE, ylbF, and ybcF are co-transcribed. Deletion of ybcF caused only a slight increase in metabolic flow into the glyoxylate pathway, probably because CP was used to de novo synthesize pyrimidine and arginine. The activity of the catabolic CK was analyzed using purified YbcF protein. The V_max is 1.82 U/mg YbcF for CP and 1.94 U/mg YbcF for ADP, and the K_M value is 0.47 mM for CP and 0.43 mM for ADP. With these results, it was experimentally revealed that the ybcF gene of E. coli encodes catabolic CK, which completes anaerobic allantoin degradation through substrate-level phosphorylation. Therefore, we suggest renaming the ybcF gene as allK.

• Biomolecules & Therapeutics
• /
• 제5권3호
• /
• pp.239-245
• /
• 1997

Trimetoquinol (TMQ) and its analogs are known to have thromboxane $A_2$ antagonistic action. We also reported that GS389, chemically similar to TMQ, has competitive antagonistic action in rat aorta and human platelets. In the present study, we investigated the pharmacological characteristics of GS283 and GS 386, analogs of GS389, using vascular smooth muscle, human platelets and rat brain homogenates. In isolated pig coronary artery (PCA), both of GS283 and GS386 relaxed U46619-contracted rings in concentration dependent manner. Pretreatment with several concentrations of GS283 and GS386 shifted the dose-response curves to the right, and reduced of maximum contration dose-dependently. Furthermore, GS283 and GS386 strongly inhibited $Ca^{2+}$ -induced contraction in the PCA. In human platelets, U46619- and A23187-induced platelet aggregation was inhibited by GS283 and GS386, concentration-dependently. Anti-platelet aggregation was related to the compound\`s ability to inhibit ATP release at each stimulation. In rat brain homogenates, receptor-binding assay resulted that both GS283 and GS386 have a relative affinity to $\alpha$-adrenergic receptor. Taken together. we concluded that the mechamism of action of GS283 and GS86 is not related with in TXA$_2$ receptor but concerned with calcium antagonistic action and a-blocking action.n.

• 대한약리학회지
• /
• 제28권1호
• /
• pp.81-89
• /
• 1992

항우울제에 속하는 imipramine은 유뇨증에 대한 치료제로서도 널리 사용되고 있다. Imipramine이 유뇨증 치료제로서의 명백한 치료효과를 보이기는 하나, 그 작용기전에 대해서는 아직 논란이 많다. 그 중 가장 유력한 설은 말초성 자율신경에 대한 작용으로서 무스카린성 길항작용과 교감신경말단에서의 catecholamine 재섭취 방해작용 및 직접적인 방광근 이완 작용 등이 제시되고 있다. 또 최근에는 방광 평활근에 대한 직접작용에 칼슘 이동 억압 작용이 중요한 역할을 한다고 주장되고 있다. 이에 본 실험에서는 흰쥐의 적출방광 배뇨근 절편을 사용하여 imipramine의 항유뇨작용과 calcium동원과의 관련성을 추구하여 다음과 같은 결과를 얻었다. 1. 배뇨근 절편은 전기장자극에 의해 주파수의존적으로 수축하였는데, 이 전기장자극 유발 수축반응은 imipramine에 의해 농도 의존적으로 억제되었고 고농도에서는 완전히 소실되었으나, atropine에 의해서는 고농도에서도 소실되지 않았다. 2. Imipramine은 자발수축 및 기본 장력에 대하여 이들을 농도 의존적인 양상으로 억제하였으며, 이 억제작용은 diltiazem에 의한 억제와 유사하였다. 그러나 atropine은 배뇨근절편의 기본장력이나 자발수축에 아무런 영향도 미치지 않았다. 3. $^*Imipramine$은 bethanechol 유발수축과 adenosine triphosphate (ATP) 유발수축을 농도의존적으로 억압하였다. 4. Imipramine은 칼슘배제용액에서 칼슘 첨가에의한 수축성의 회복을 억제하였는데, 이러한 작용은 diltiazem보다 그 효력이 낮았으나 그 작용양상은 유사하였다. 5. Imipramine에 의해 감소되었던 배뇨근절편의 기본장력은 calcium ionophore인 A23187에 의해 회복되었다. 칼슘배제 영양액에 장시간 노출됨으로써 기본장력은 소실되었으며, imipramine을 전처치한 경우는 A23187첨가에 의해 장력이 회복되지 않았으나, 세포내칼슘 유리억제제인 trimethoxybenzoic acid 8-(diethylamino)octyl ester [TMB-8]을 전처치한 경우 A23187은 배뇨근의 기본장력을 현저히 회복시켰다. 이상의 결과로 미루어 보아 imipramine의 배뇨근 수축 억제작용의 기전에는 무스카린성 및 퓨린성 수용체봉쇄작용도 관여하나, 주된 기전은 평활근세포에 직접 작용하여 세포외 칼슘의 유입을 억제하는 것으로 사료된다.

• The Korean Journal of Physiology
• /
• 제24권1호
• /
• pp.1-13
• /
• 1990

기니피그 유문동 부위를 절제한 뒤 점막층을 박리하고 윤상근 주행방향으로 길이 10 mm, 너비 2 mm 되는 조직 절편을 만들어 수평형 실험용기에 넣어 핀으로 고정하였다. 유리미세전극을 세포내에 삽입하여 서파를 기록하면서 조직양편에 설치한 백금자극전극(직경 0.5 mm)에 강도 $10{\sim}50V$, 기간 $50{\sim}100\;{\mu}s$ 되는 자극파를 주어 신경-근 부위의 접합부 전압을 기록하여 다음과 같은 결과를 얻었다. 1) 위저부에서는 흥분성 접합부 전압이, 유문동에서는 억제성 접합부 전압이 기록되었고 유문동의 억제성 접합부 전압은 atropine($10^{-6}\;M)$과 guanethidine$(5{\times}10^{-6}\;M)$을 동시 처치했을 때 영향을 받지 않았다. 2) 세포외 $Ca^{2+}$ 농도를 높였을 때(7 mM)는 억제성 접합부 전압의 크기가 증가하고 세포외 $Mg^{2+}$ 농도를 높였을 때(5 mM)와 verapamil($10^{-5}\;M$)을 주었을 때는 억제성 접합부 전압의 크기가 감소하였다. 3) 아데노신을 투여하였을 때와 ATP를 투여했을 때는 모두 억제성 접합부 전압의 크기가 감소하였다. 4) 5-HT$(10^{-6}\;M)$을 투여했을 때는 서파크기에는 변화없이 억제성 접합부 전압의 크기만 감소하였고 5-HT type 2 길항제인 ketanserin$(5{\times}10^{-6}\;M)$을 투여했을 때는 서파크기는 현저히 감소한 반면 억제성 접합부 전압크기는 변화가 없었다. 이상의 결과로부터 유문동에서 기록되는 억제성 접합부 전압은 비아드레날린, 비콜린 동작성 신경에 의해 유발되며 $Ca^{2+}$은 비아드레날린 비콜린 동작성 신경에서 신경흥분전달물질의 유리를 촉진시키고 분비된 신경흥분전달물질로 인해 $Ca^{2+}$ 의존성 $K^{+}$ 통로가 활성화되어 억제성 접합부 전압의 크기를 증가시킨다고 사료된다.

• 생태와환경
• /
• 제37권4호통권109호
• /
• pp.436-447
• /
• 2004

습지를 규정하는 주요한 특징의 하나인 습지식물은 장기간의 침수로 인해 혐기성 상태로 존재하는 습지 퇴적물에서 생존을 위한 특별한 적응방법을 발달시켰다. 식물체내에 넓게 분포하고 있는 다공성의 세포는 공기중의 산소를 뿌리로 운반하기 위한 통로로 작용하며, 농도차이에 의한 확산과 압력차이에 의한 대류에 의하여 산소가 운반되어진다. 이러한 식물체 내에서의 산소이동은 식물이 혐기성 퇴적물 속으로 뿌리를 내리고 생존하게 하는 주요한 기작이 된다. 뿌리로 이동되어진 산소는 혐기성 퇴적물로 확산되어져서 뿌리주변의 퇴적물은 산화상태로 변화시키고, 뿌리의 호흡, 미생물의 호흡, 미생물에 의한 유기물 분해반응을 촉진시키게 된다. 또한 습지식물은 생장에 필요한 수분을 뿌리로 흡수하며, 이는 지표수와 퇴적물내 공극수가 뿌리주변으로 이동하게 되는 추진력이 된다. 습지 퇴적물은 식물의 사체에서 기인하는 유기물에 의해 수리학적 전도도가 작아서 퇴적물내 물의 움직임이 미미하나, 식물에 의한 물의 흡수는 퇴적물내 물의 움직임을 촉진시키게 된다. 이러한 식물의 특별한 적응기작은 해부학적, 형태학적, 생리학적으로 많은 연구가 수행되어져 왔으나, 이러한 적응기작들에 퇴적물내 생지화학적 반응에 미치는 영향에 대한 연구는 미비한 수준에 머물러있다. 퇴적물내 생지화학적 반응들은 수체에서 유입된 미량 오염물질의 이동 및 변형과정에 영향을 미치게 되므로 식물의 작용에 의한 생지화학적 반응의 변화들은 미량 오염물질의 거동에 영향을 미치게 되며 나아가 수자원과 수질 생태계에 영향을 초래하게 된다. 따라서 식물의 존재와 성장에 따른 퇴적물내 생지화학적 반응의 변화는 생태학적 환경에서 습지의 중요성을 인식하는데 필요한 연구과제라 사료된다. 난이도, 변별도 등에서 유사하므로 당분간 계속 사용하여도 될 것이다. 따른 변화(變化)는 볼 수 없었다. ATP 첨가(添加)로서는 0.30mM의 농도(濃度)에서 0.15 mM의 농도(濃度)에 비(比)하여 Young 율(率)이 낮았다. 3) 외경동맥(外經動脈)의 종절편(縱切片)의 Young 율(率)은 생리적식염수(生理的食鹽水)에 둔 군(群)에서는 15분(分), 45분(分) 및 75분(分)에서 각각(各各) 2.12, 2.48 및 $2.46{\times}10^7 dyne/cm^2$으로서 실험초기(實驗初期)에 비(比)하여 후기(後期)에서 Young 율(率)이 약간(若干) 높은 경향(傾向)을 나타내었고, 이러한 경향(傾向)은 ATP의 첨가(添加)로서도 비슷하였다.수량(收量)과 자실체형성(子實體形成) 소요일(所要日)의 관점(觀點)에서 보면 C/N율(率) 30.46이 어느정도 적당(適當)한 것 같다. 4. Thiamine $50{\mu}g%,\;KH_2PO_4$ 0.2%, $MgSO_4{\cdot}7H_2O$는 $0.02{\sim}0.03%$일때 균사(菌絲)와 자실체(子實體) 생육(生育)이 우수(優秀)하였으며 미량원소(微量元素)로서는 $FeSO_4{\cdot}7H_2O$,\;ZnSO_4{\cdot}7H_2O$ 및 $MnSO_4{\cdot}5H_2O$가 공존(共存)하면 생육촉진(生育促進)의 상승효과(相乘效果)가 인정되었으나 3이원소(元素)중 Mn이 결핍(缺乏)하면 균사(菌絲)와 자실체(子實體)의 생육(生育)이 다소 저하되었다. 이들 염류(鹽類)의 최적농도(最適濃度)는 각각 0.02mg%이었다. 5.

• Journal of Ginseng Research
• /
• 제41권4호
• /
• pp.548-555
• /
• 2017

Background: Korean Red Ginseng has been used for several decades to treat many diseases, enhancing both immunity and physical strength. Previous studies have documented the therapeutic effects of ginseng, including its anticancer, antiaging, and anti-inflammatory activities. These activities are mediated by ginsenosides present in the ginseng plant. Ginsenoside Rg3, an effective compound from red ginseng, has been shown to have antiplatelet activity in addition to its anticancer and anti-inflammatory activities. Platelets are important for both primary hemostasis and the repair of the vessels after injury; however, they also play a crucial role in the development of acute coronary diseases. We prepared ginsenoside Rg3-enriched red ginseng extract (Rg3-RGE) to examine its role in platelet physiology. Methods: To examine the effect of Rg3-RGE on platelet activation in vitro, platelet aggregation, granule secretion, intracellular calcium ($[Ca^{2+}]_i$) mobilization, flow cytometry, and immunoblot analysis were carried out using rat platelets. To examine the effect of Rg3-RGE on platelet activation in vivo, a collagen plus epinephrine-induced acute pulmonary thromboembolism mouse model was used. Results: We found that Rg3-RGE significantly inhibited collagen-induced platelet aggregation and $[Ca^{2+}]_i$ mobilization in a dose-dependent manner in addition to reducing ATP release from collagen-stimulated platelets. Furthermore, using immunoblot analysis, we found that Rg3-RGE markedly suppressed mitogen-activated protein kinase phosphorylation (i.e., extracellular stimuli-responsive kinase, Jun N-terminal kinase, p38) as well as the PI3K (phosphatidylinositol 3 kinase)/Akt pathway. Moreover, Rg3-RGE effectively reduced collagen plus epinephrine-induced mortality in mice. Conclusion: These data suggest that ginsenoside Rg3-RGE could be potentially be used as an antiplatelet therapeutic agent against platelet-mediated cardiovascular disorders.

• Asian-Australasian Journal of Animal Sciences
• /
• 제18권4호
• /
• pp.483-489
• /
• 2005

To understand the molecular mechanisms that regulate intramuscular fat deposition and its release, cDNA clones expressed in adipose tissues of Korean cattle were identified by differential screening from adipose tissue cDNA library. By partial nucleotide sequencing of 486 clones and a search for sequence similarity in NCBI nucleotide databases, 245 clones revealed unique clones. By a functional grouping of the clones, 14% of the clones were categorized to metabolism and enzyme-related group (stearoyl CoA desaturase, lactate dehydrogenase, fatty acid synthase, ATP citrate lyase, lipoprotein lipase, acetyl CoA synthetase, etc), and 6% to signal transduction/cell cycle-related group (C/EBP, cAMP-regulated phosphoprotein, calmodulin, cyclin G1, cyclin H, etc), and 4% to cytoskeleton and extracellular matrix components (vimentin, ankyrin 2, gelosin, syntenin, talin, prefoldin 5). The obtained 245 clones will be useful to study lipid metabolism and signal transduction pathway in adipose tissues and to study obesity in human. Some clones were subjected to full-sequencing containing open reading frame. The cDNA clone of bovine homolog of human prefoldin 5 gene had a total length of 959 nucleotides coding for 139 amino acids. Comparison of the deduced amino acid sequences of bovine prefoldin 5 with those of human and mouse showed over 95% identity. The cDNA clone of bovine homolog of human ubiquitin-like/S30 ribosomal fusion protein gene had a total length of 484 nucleotides coding for 133 amino acids. Comparison of the deduced amino acid sequences of bovine ubiquitin-like/S30 ribosomal fusion protein gene with those of human, rat and mouse showed over 97% identity. The cDNA clone of bovine homolog of human proteolipid protein 2 mRNA had a total length of 928 nucleotides coding for 152 amino acids. Comparison of the deduced amino acid sequences of bovine proteolipid protein 2 with those of human and mouse showed 87.5% similarity. The cDNA clone of bovine homolog of rat thymosin beta 4 had a total length of 602 nucleotides coding for 44 amino acids. Comparison of the deduced amino acid sequences of bovine thymosin beta 4 gene with those of human, mouse and rat showed 93.1% similarity. The cDNA clone of bovine homolog of human myotrophin mRNA had a total length of 790 nucleotides coding for 118 amino acids. Comparison of the deduced amino acid sequences of bovine myotrophin gene with those of human, mouse and rat showed 83.9% similarity. The functional role of these clones in adipose tissues needs to be established.

• Biomolecules & Therapeutics
• /
• 제32권1호
• /
• pp.104-114
• /
• 2024

Licochalcone C (LCC; PubChem CID:9840805), a chalcone compound originating from the root of Glycyrrhiza inflata, has shown anticancer activity against skin cancer, esophageal squamous cell carcinoma, and oral squamous cell carcinoma. However, the therapeutic potential of LCC in treating colorectal cancer (CRC) and its underlying molecular mechanisms remain unclear. Chemotherapy for CRC is challenging because of the development of drug resistance. In this study, we examined the antiproliferative activity of LCC in human colorectal carcinoma HCT116 cells, oxaliplatin (Ox) sensitive and Ox-resistant HCT116 cells (HCT116-OxR). LCC significantly and selectively inhibited the growth of HCT116 and HCT116-OxR cells. An in vitro kinase assay showed that LCC inhibited the kinase activities of EGFR and AKT. Molecular docking simulations using AutoDock Vina indicated that LCC could be in ATP-binding pockets. Decreased phosphorylation of EGFR and AKT was observed in the LCC-treated cells. In addition, LCC induced cell cycle arrest by modulating the expression of cell cycle regulators p21, p27, cyclin B1, and cdc2. LCC treatment induced ROS generation in CRC cells, and the ROS induction was accompanied by the phosphorylation of JNK and p38 kinases. Moreover, LCC dysregulated mitochondrial membrane potential (MMP), and the disruption of MMP resulted in the release of cytochrome c into the cytoplasm and activation of caspases to execute apoptosis. Overall, LCC showed anticancer activity against both Ox-sensitive and Ox-resistant CRC cells by targeting EGFR and AKT, inducing ROS generation and disrupting MMP. Thus, LCC may be potential therapeutic agents for the treatment of Ox-resistant CRC cells.